Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. The firm design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
Innovation within the pharma industry is rife. But with innovation comes new and complex regulatory frameworks. The impeding impact of Brexit could also further increase this complexity, but while the shift will have a considerable effect, Dr Maureen Graham, MD of Diamond Pharma is optimistic about a post-Brexit world.
Uncertainty continues to linger around the potential impact of Brexit. After the Government’s admission that the long awaited parliamentary reports detailing how Brexit would affect key economic sectors didn’t actually exist, new reports looking at the Brexit impact have since showed various scenarios.
Crucial gains for disability rights secured by the business community must not be reversed post-Brexit due to a lack of planning and preparation, Business Disability Forum has warned.
Shortage of Skills Threatens UK’s Potential in Technology & Innovation post-Brexit, MPs warned
If the UK leaves the EU in 2019 with no deal permitting access to the single market and customs union, it could cost the economy £237,823 every minute of every day in lost economic output by 2020
ALSO launches partnership with Scale Computing across Europe.
SAP Helps Businesses Across Europe and the Middle East Put People at the Center of Business
EclecticIQ lands series-b investment of €14 million to make cyber threat intelligence accessible to organizations at any level of cyber readiness.
Desktop Metal, the company committed to bringing metal 3D printing to engineers and manufacturers, announced on the 13th November it will begin accepting international pre-orders of its metal 3D printing system, the Studio System™ from companies throughout Europe.
Today, the CJEU manifestly ruled that enforcement actions against EU licensed operators unlawfully excluded from national licensing processes are prohibited and not in compliance with EU law
